Brogan P A, Shah V, Clarke L A, Dillon M J, Klein N
Department of Rheumatology, Institute of Child Health and Great Ormond St Hospital for Children, London, UK.
Clin Exp Immunol. 2008 Feb;151(2):267-74. doi: 10.1111/j.1365-2249.2007.03567.x. Epub 2007 Dec 6.
Superantigens (SAgs) are potent stimulators of T cells bearing specific Vbeta T cell receptors (TCR) and may play a role in the pathogenesis of Kawasaki syndrome (KS), although despite 15 years of intense study this area remains controversial. Because SAgs can cause Vbeta restricted T cell activation in the absence of Vbeta skewing the aims of this study were to describe a flow cytometric protocol to study both CD4 and CD8 Vbeta repertoires, and CD69 expression across the CD4 and CD8 Vbeta repertoire in children with KS. Sixteen children with KS were studied. There was no significant increase in overall peripheral blood CD4 or CD8 T cell activation as determined by CD69 expression. However, Vbeta restricted CD4 and/or CD8 activation was observed in eight of 11 (72%) of the KS patients, a finding not observed in healthy controls. Thirteen of 16 (81%) of the KS patients had evidence of either Vbeta skewing (particularly CD4 Vbeta2 and Vbeta5.1) and/or Vbeta restricted activation. Three patients had Vbeta restricted activation in the absence of skewing. We suggest that these preliminary observations highlight the many layers of complexity when considering T cell activation in KS, which could explain some of the conflicting studies regarding peripheral blood T cell activation and Vbeta skewing. It is likely that in order to move forward with this debate a combination of detailed microbiological, immunological and molecular techniques applied to individual patients will be required ultimately to prove or refute the SAg hypothesis of KS.
超抗原(SAgs)是带有特定VβT细胞受体(TCR)的T细胞的强效刺激剂,可能在川崎病(KS)的发病机制中起作用,尽管经过15年的深入研究,该领域仍存在争议。由于超抗原可在不存在Vβ偏斜的情况下引起Vβ限制性T细胞活化,本研究的目的是描述一种流式细胞术方案,以研究KS患儿的CD4和CD8 Vβ库,以及CD4和CD8 Vβ库中的CD69表达。对16名KS患儿进行了研究。通过CD69表达确定,外周血中总的CD4或CD8 T细胞活化没有显著增加。然而,在11名KS患者中的8名(72%)中观察到Vβ限制性CD4和/或CD8活化,这一发现未在健康对照中观察到。16名KS患者中的13名(81%)有Vβ偏斜(特别是CD4 Vβ2和Vβ5.1)和/或Vβ限制性活化的证据。3名患者在没有偏斜的情况下有Vβ限制性活化。我们认为,这些初步观察结果突出了在考虑KS中的T细胞活化时存在的许多复杂层面,这可以解释一些关于外周血T细胞活化和Vβ偏斜的相互矛盾的研究。为了推进这场辩论,最终可能需要将详细的微生物学、免疫学和分子技术结合应用于个体患者,以证明或反驳KS的超抗原假说。